Prevention of β-amyloid induced toxicity in human iPS cell-derived neurons by inhibition of Cyclin-dependent kinases and associated cell cycle events

Stem Cell Research

Volumn 10, Issue 2, 2013, Pages 213-227

  Xu, Xiaohong ^a,b   Lei, Ying ^b   Luo, Jie ^b   Wang, Jamie ^b   Zhang, Shu ^b   Yang, Xiu Juan ^b   Sun, Mu ^b   Nuwaysir, Emile ^c   Fan, Guohuang ^b   Zhao, Jing ^b   Lei, Lei ^a   Zhong, Zhong ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b GLAXOSMITHKLINE   (China)

^c Cellular Dynamics International Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CYCLIN DEPENDENT KINASE 2;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS; FLOW CYTOMETRY; FOREBRAIN; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LIMIT OF QUANTITATION; NERVE CELL; NERVE CELL DIFFERENTIATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION;

AMYLOID BETA-PEPTIDES; CELL CYCLE; CELL DEATH; CYCLIN-DEPENDENT KINASES; HUMANS; IMMUNOBLOTTING; INDUCED PLURIPOTENT STEM CELLS; NEURONS; PEPTIDE FRAGMENTS; PROSENCEPHALON; PROTECTIVE AGENTS; PROTEIN KINASE INHIBITORS; PROTEIN STRUCTURE, QUATERNARY; REPRODUCIBILITY OF RESULTS;

IPS;

EID: 84872171503     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2012.11.005     Document Type: Article

References (73)

1. Bardy J., Chen A., Lim Y.M., Wu S.M., Wei S., Han W., Chan K.K., Reuveny S., Oh S. Microcarrier suspension cultures for high density expansion and differentiation of human pluripotent stem cells to neural progenitor cells. Tissue Eng. Part C Methods 2012, 10.1089/ten.TEC.2012.0146.
2. Baumann K., Mandelkow E.M., Biernat J., Piwnica-Worms H., Mandelkow E. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett. 1993, 336:417-424.
3. Bissonnette C.J., Lyass L., Bhattacharyya B.J., Belmadani A., Miller R.J., Kessler J.A. The controlled generation of functional basal forebrain cholinergic neurons from human embryonic stem cells. Stem Cells 2011, 29:802-811.
4. Biswas S.C., Liu D.X., Greene L.A. Bim is a direct target of a neuronal E2F-dependent apoptotic pathway. J. Neurosci. 2005, 25:8349-8358.
5. Bonda D.J., Evans T.A., Santocanale C., Llosa J.C., Vina J., Bajic V.P., Castellani R.J., Siedlak S.L., Perry G., Smith M.A., Lee H.G. Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease. Aging 2009, 1:382-388.
6. Brennand K.J., Simone A., Jou J., Gelboin-Burkhart C., Tran N., Sangar S., Li Y., Mu Y., Chen G., Yu D., McCarthy S., Sebat J., Gage F.H. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2010, 473:221-225.
7. Busser J., Geldmacher D.S., Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J. Neurosci. 1998, 18:2801-2807.
8. Chai X., Dage J.L., Citron M. Constitutive secretion of tau protein by an unconventional mechanism. Neurobiol. Dis. 2012, 48:356-366.
9. Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 2009, 27:275-280.
10. Copani A., Condorelli F., Caruso A., Vancheri C., Sala A., Giuffrida Stella A.M., Canonico P.L., Nicoletti F., Sortino M.A. Mitotic signaling by beta-amyloid causes neuronal death. FASEB J. 1999, 13:2225-2234.
11. Copani A., Uberti D., Sortino M.A., Bruno V., Nicoletti F., Memo M. Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path?. Trends Neurosci. 2001, 24:25-31.
12. Crittenden J.R., Heidersbach A., McManus M.T. Lentiviral strategies for RNAi knockdown of neuronal genes. Curr. Protoc. Neurosci. 2007, 5.26.1-5.26.21. (Chapter 5, Unit 5.26).
13. Cummings B.J., Cotman C.W. Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet 1995, 346:1524-1528.
14. Dahlgren K.N., Manelli A.M., Stine W.B., Baker L.K., Krafft G.A., LaDu M.J. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 2002, 277:32046-32053.
15. Danysz W., Parsons C.G., Mobius H.J., Stoffler A., Quack G. Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease-a unified glutamatergic hypothesis on the mechanism of action. Neurotox. Res. 2000, 2:85-97.
16. Davis S.T., Benson B.G., Bramson H.N., Chapman D.E., Dickerson S.H., Dold K.M., Eberwein D.J., Edelstein M., Frye S.V., Gampe R.T., Griffin R.J., Harris P.A., Hassell A.M., Holmes W.D., Hunter R.N., Knick V.B., Lackey K., Lovejoy B., Luzzio M.J., Murray D., Parker P., Rocque W.J., Shewchuk L., Veal J.M., Walker D.H., Kuyper L.F. Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors. Science 2001, 291:134-137.
17. Dimos J.T., Rodolfa K.T., Niakan K.K., Weisenthal L.M., Mitsumoto H., Chung W., Croft G.F., Saphier G., Leibel R., Goland R., Wichterle H., Henderson C.E., Eggan K. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008, 321:1218-1221.
18. Ebert A.D., Yu J., Rose F.F., Mattis V.B., Lorson C.L., Thomson J.A., Svendsen C.N. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457:277-280.
19. Eischen C.M., Packham G., Nip J., Fee B.E., Hiebert S.W., Zambetti G.P., Cleveland J.L. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Oncogene 2001, 20:6983-6993.
20. Frasca G., Chiechio S., Vancheri C., Nicoletti F., Copani A., Angela Sortino M. Beta-amyloid-activated cell cycle in SH-SY5Y neuroblastoma cells: correlation with the MAP kinase pathway. J. Mol. Neurosci. 2004, 22:231-236.
21. Furukawa Y., Nishimura N., Furukawa Y., Satoh M., Endo H., Iwase S., Yamada H., Matsuda M., Kano Y., Nakamura M. Apaf-1 is a mediator of E2F-1-induced apoptosis. J. Biol. Chem. 2002, 277:39760-39768.
22. Giovanni A., Wirtz-Brugger F., Keramaris E., Slack R., Park D.S. Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death. J. Biol. Chem. 1999, 274:19011-19016.
23. Grant E.R., Errico M.A., Emanuel S.L., Benjamin D., McMillian M.K., Wadsworth S.A., Zivin R.A., Zhong Z. Protection against glutamate toxicity through inhibition of the p44/42 mitogen-activated protein kinase pathway in neuronally differentiated P19 cells. Biochem. Pharmacol. 2001, 62:283-296.
24. Greene L.A., Liu D.X., Troy C.M., Biswas S.C. Cell cycle molecules define a pathway required for neuron death in development and disease. Biochim. Biophys. Acta 2007, 1772:392-401.
25. Hester M.E., Murtha M.J., Song S., Rao M., Miranda C.J., Meyer K., Tian J., Boulting G., Schaffer D.V., Zhu M.X., Pfaff S.L., Gage F.H., Kaspar B.K. Rapid and efficient generation of functional motor neurons from human pluripotent stem cells using gene delivered transcription factor codes. Mol. Ther. 2009, 19:1905-1912.
26. Hilton G.D., Stoica B.A., Byrnes K.R., Faden A.I. Roscovitine reduces neuronal loss, glial activation, and neurologic deficits after brain trauma. J. Cereb. Blood Flow Metab. 2008, 28:1845-1859.
27. Inaguma Y., Shinohara H., Inagaki T., Kato K. Immunoreactive parvalbumin concentrations in parahippocampal gyrus decrease in patients with Alzheimer's disease. J. Neurol. Sci. 1992, 110:57-61.
28. Israel M.A., Yuan S.H., Bardy C., Reyna S.M., Mu Y., Herrera C., Hefferan M.P., Van Gorp S., Nazor K.L., Boscolo F.S., Carson C.T., Laurent L.C., Marsala M., Gage F.H., Remes A.M., Koo E.H., Goldstein L.S. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 2012, 482:216-220.
29. Jorda E.G., Verdaguer E., Canudas A.M., Jimenez A., Bruna A., Caelles C., Bravo R., Escubedo E., Pubill D., Camarasa J., Pallas M., Camins A. Neuroprotective action of flavopiridol, a cyclin-dependent kinase inhibitor, in colchicine-induced apoptosis. Neuropharmacology 2003, 45:672-683.
30. Konishi Y., Bonni A. The E2F-Cdc2 cell-cycle pathway specifically mediates activity deprivation-induced apoptosis of postmitotic neurons. J. Neurosci. 2003, 23:1649-1658.
31. Krantic S., Isorce N., Mechawar N., Davoli M.A., Vignault E., Albuquerque M., Chabot J.G., Moyse E., Chauvin J.P., Aubert I., McLaurin J., Quirion R. Hippocampal GABAergic neurons are susceptible to amyloid-beta toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model. J. Alzheimer's Dis. 2011, 29:293-308.
32. Laustriat D., Gide J., Peschanski M. Human pluripotent stem cells in drug discovery and predictive toxicology. Biochem. Soc. Trans. 2010, 38:1051-1057.
33. Lee G., Papapetrou E.P., Kim H., Chambers S.M., Tomishima M.J., Fasano C.A., Ganat Y.M., Menon J., Shimizu F., Viale A., Tabar V., Sadelain M., Studer L. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 2009, 461:402-406.
34. Lim A.C., Qi R.Z. Cyclin-dependent kinases in neural development and degeneration. J. Alzheimer's Dis. 2003, 5:329-335.
35. Liu H., Zhang S.C. Specification of neuronal and glial subtypes from human pluripotent stem cells. Cell. Mol. Life Sci. 2011, 68:3995-4008.
36. Lopez-Bergami P., Ronai Z. Requirements for PKC-augmented JNK activation by MKK4/7. Int. J. Biochem. Cell Biol. 2008, 40:1055-1064.
37. Mattson M.P., Magnus T. Ageing and neuronal vulnerability. Nat. Rev. Neurosci. 2006, 7:278-294.
38. Mikkonen M., Alafuzoff I., Tapiola T., Soininen H., Miettinen R. Subfield-and layer-specific changes in parvalbumin, calretinin and calbindin-D28K immunoreactivity in the entorhinal cortex in Alzheimer's disease. Neuroscience 1999, 92:515-532.
39. Mosch B., Morawski M., Mittag A., Lenz D., Tarnok A., Arendt T. Aneuploidy and DNA replication in the normal human brain and Alzheimer's disease. J. Neurosci. 2007, 27:6859-6867.
40. Muir J.L., Everitt B.J., Robbins T.W. AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J. Neurosci. 1994, 14:2313-2326.
41. Nevins J.R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992, 258:424-429.
42. Nguyen L., Wright S., Lee M., Ren Z., Sauer J.M., Hoffman W., Zago W., Kinney G.G., Bova M.P. Quantifying amyloid beta (abeta)-mediated changes in neuronal morphology in primary cultures: implications for phenotypic screening. J. Biomol. Screen. 2012, 17:835-842.
43. Osuga H., Osuga S., Wang F., Fetni R., Hogan M.J., Slack R.S., Hakim A.M., Ikeda J.E., Park D.S. Cyclin-dependent kinases as a therapeutic target for stroke. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:10254-10259.
44. Pakaski M., Farkas Z., Kasa P., Forgon M., Papp H., Zarandi M., Penke B., Kasa P. Vulnerability of small GABAergic neurons to human beta-amyloid pentapeptide. Brain Res. 1998, 796:239-246.
45. Park D.S., Levine B., Ferrari G., Greene L.A. Cyclin dependent kinase inhibitors and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons. J. Neurosci. 1997, 17:8975-8983.
46. Petit I., Kesner N.S., Karry R., Robicsek O., Aberdam E., Muller F.J., Aberdam D., Ben-Shachar D. Induced pluripotent stem cells from hair follicles as a cellular model for neurodevelopmental disorders. Stem Cell Res. 2011, 8:134-140.
47. Phillips A.C., Ernst M.K., Bates S., Rice N.R., Vousden K.H. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. Mol. Cell 1999, 4:771-781.
48. Prescott C. The business of exploiting induced pluripotent stem cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2011, 366:2323-2328.
49. Ranganathan S., Bowser R. Alterations in G 1 to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am. J. Pathol. 2003, 162:823-835.
50. Ranganathan S., Scudiere S., Bowser R. Hyperphosphorylation of the retinoblastoma gene product and altered subcellular distribution of E2F-1 during Alzheimer's disease and amyotrophic lateral sclerosis. J. Alzheimer's Dis. 2001, 3:377-385.
51. Schor N.F. What the halted phase III gamma-secretase inhibitor trial may (or may not) be telling us. Ann. Neurol. 2011, 69:237-239.
52. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
53. Shi Y., Kirwan P., Smith J., MacLean G., Orkin S.H., Livesey F.J. A human stem cell model of early Alzheimer's disease pathology in Down syndrome. Sci. Transl. Med. 2012, 4:124-129.
54. Sielecki T.M., Boylan J.F., Benfield P.A., Trainor G.L. Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulation. J. Med. Chem. 2000, 43:1-18.
55. Smith M., Nagy Z., Esiri M. Cell cycle-related protein expression in vascular dementia and Alzheimer's disease. Neurosci. Lett. 1999, 271:45-48.
56. Smith P.D., O'Hare M.J., Park D.S. CDKs: taking on a role as mediators of dopaminergic loss in Parkinson's disease. Trends Mol. Med. 2004, 10:445-451.
57. Song B., Sun G., Herszfeld D., Sylvain A., Campanale N.V., Hirst C.E., Caine S., Parkington H.C., Tonta M.A., Coleman H.A., Short M., Ricardo S.D., Reubinoff B., Bernard C.C. Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis. Stem Cell Res. 2011, 8:259-273.
58. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
59. Takahashi H., Brasnjevic I., Rutten B.P., Van Der Kolk N., Perl D.P., Bouras C., Steinbusch H.W., Schmitz C., Hof P.R., Dickstein D.L. Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer's disease. Brain Struct. Funct. 2010, 214:145-160.
60. Troy C.M., Rabacchi S.A., Friedman W.J., Frappier T.F., Brown K., Shelanski M.L. Caspase-2 mediates neuronal cell death induced by beta-amyloid. J. Neurosci. 2000, 20:1386-1392.
61. Varvel N.H., Bhaskar K., Patil A.R., Pimplikar S.W., Herrup K., Lamb B.T. Abeta oligomers induce neuronal cell cycle events in Alzheimer's disease. J. Neurosci. 2008, 28:10786-10793.
62. Vassar R. beta-Secretase, APP and Abeta in Alzheimer's disease. Subcell. Biochem. 2005, 38:79-103.
63. Vincent I., Rosado M., Davies P. Mitotic mechanisms in Alzheimer's disease?. J. Cell Biol. 1996, 132:413-425.
64. Wei H., Tan G., Manasi, Qiu S., Kong G., Yong P., Koh C., Ooi T.H., Lim S.Y., Wong P., Gan S.U., Shim W. One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells. Stem Cell Res. 2012, 9:87-100.
65. Whitemarsh R.C., Strathman M.J., Chase L.G., Stankewicz C., Tepp W.H., Johnson E.A., Pellett S. Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection. Toxicol. Sci. 2012, 126:426-435.
66. Yagi T., Ito D., Okada Y., Akamatsu W., Nihei Y., Yoshizaki T., Yamanaka S., Okano H., Suzuki N. Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum. Mol. Genet. 2011, 20:4530-4539.
67. Yang Y., Geldmacher D.S., Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J. Neurosci. 2001, 21:2661-2668.
68. Yang Y., Mufson E.J., Herrup K. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J. Neurosci. 2003, 23:2557-2563.
69. Ye W., Blain S.W. S phase entry causes homocysteine-induced death while ataxia telangiectasia and Rad3 related protein functions anti-apoptotically to protect neurons. Brain 2010, 133:2295-2312.
70. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
71. Zeng H., Guo M., Martins-Taylor K., Wang X., Zhang Z., Park J.W., Zhan S., Kronenberg M.S., Lichtler A., Liu H.X., Chen F.P., Yue L., Li X.J., Xu R.H. Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells. PLoS One 2010, 5:e11853.
72. Zhang D., Jiang W., Liu M., Sui X., Yin X., Chen S., Shi Y., Deng H. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res. 2009, 19:429-438.
73. Zhou T., Benda C., Duzinger S., Huang Y., Li X., Li Y., Guo X., Cao G., Chen S., Hao L., Chan Y.C., Ng K.M., Ho J.C., Wieser M., Wu J., Redl H., Tse H.F., Grillari J., Grillari-Voglauer R., Pei D., Esteban M.A. Generation of induced pluripotent stem cells from urine. J. Am. Soc. Nephrol. 2011, 22:1221-1228.